Investigative Ophthalmology & Visual Science, Vol 38, 1865-1872, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma

DJ Blom, GP Luyten, C Mooy, S Kerkvliet, AH Zwinderman and MJ Jager
Department of Ophthalmology, Leiden University Hospital, The Netherlands.

PURPOSE: Because the expression of human leukocyte antigen (HLA) antigens is important for immunologic recognition of tumor cells, we determined expression of locus-specific HLA class I antigens in uveal melanoma and tested whether the level of HLA expression was related to prognosis or associated with known prognostic parameters. METHODS: Expression of HLA-A and -B antigens was determined on 30 formalin-fixed and paraffin-embedded sections of uveal melanoma by immunohistochemistry with locus-specific monoclonal antibodies and scored semiquantitatively. RESULTS: The level of expression of HLA-A and -B varied between uveal melanomas. Expression levels of HLA-A and - B were significantly correlated (P = 0.02). High HLA-B expression was significantly correlated with the presence of epithelioid cells (P = 0.04) in the tumor. Expression levels of HLA-A as well as of HLA-B, cell type, mitotic rate, Mib-1 score, and largest tumor diameter were significant predictive factors for survival. High expression of HLA-A and -B was associated with a decreased survival. Multiple Cox regression analysis with stepwise selection of covariates showed that the contribution of HLA-A expression to survival (P = 0.0003) exceeded that of tumor diameter (P = 0.02) and Mib-1 score (P = 0.04). CONCLUSIONS: Lack of expression of HLA-A as well as of HLA-B antigens on uveal melanoma is correlated with a better patient survival. Our data suggest that shedding of uveal melanoma micrometastases with a low expression of HLA class I into the systemic circulation may facilitate their removal and prevent the development of metastases. These findings support a protective role for natural killer cells in the development of metastatic disease in uveal melanoma.

This article has been cited by other articles:

				K. Hallermalm, K. Seki, A. De Geer, B. Motyka, R. C. Bleackley, M. J. Jager, C. J. Froelich, R. Kiessling, V. Levitsky, and J. Levitskaya Modulation of the Tumor Cell Phenotype by IFN-{gamma} Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes J. Immunol., March 15, 2008; 180(6): 3766 - 3774. [Abstract] [Full Text] [PDF]

				W. Maat, L. V. Ly, E. S. Jordanova, D. de Wolff-Rouendaal, N. E. Schalij-Delfos, and M. J. Jager Monosomy of Chromosome 3 and an Inflammatory Phenotype Occur Together in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 505 - 510. [Abstract] [Full Text] [PDF]

				W. Maat, G. W. Haasnoot, F. H. J. Claas, N. E. Schalij-Delfos, G. M. T. Schreuder, and M. J. Jager HLA Class I and II Genotype in Uveal Melanoma: Relation to Occurrence and Prognosis Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 3 - 6. [Abstract] [Full Text] [PDF]

				E. Ryschich, T. Notzel, U. Hinz, F. Autschbach, J. Ferguson, I. Simon, J. Weitz, B. Frohlich, E. Klar, M. W. Buchler, et al. Control of T-Cell-Mediated Immune Response by HLA Class I in Human Pancreatic Carcinoma Clin. Cancer Res., January 15, 2005; 11(2): 498 - 504. [Abstract] [Full Text] [PDF]

				Y.-G. He, E. Mayhew, J. Mellon, and J. Y. Niederkorn Expression and Possible Function of IL-2 and IL-15 Receptors on Human Uveal Melanoma Cells Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4240 - 4246. [Abstract] [Full Text] [PDF]

				H. Yang, S. Dithmar, and H. E. Grossniklaus Interferon {alpha}2b Decreases Hepatic Micrometastasis in a Murine Model of Ocular Melanoma by Activation of Intrinsic Hepatic Natural Killer Cells Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2056 - 2064. [Abstract] [Full Text] [PDF]

				S Krishnakumar, S A Lakshmi, D Abhyankar, and J Biswas Transporter associated protein expression in uveal melanoma Br. J. Ophthalmol., July 1, 2004; 88(7): 925 - 928. [Abstract] [Full Text] [PDF]

				S. Krishnakumar, D. Abhyankar, A. L. Sundaram, V. Pushparaj, M. P. Shanmugam, and J. Biswas Major Histocompatibility Antigens and Antigen-processing Molecules in Uveal Melanoma Clin. Cancer Res., September 15, 2003; 9(11): 4159 - 4164. [Abstract] [Full Text] [PDF]

				H. Alizadeh, K. Howard, J. Mellon, E. Mayhew, D. Rusciano, and J. Y. Niederkorn Reduction of Liver Metastasis of Intraocular Melanoma by Interferon-{beta} Gene Transfer Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3042 - 3051. [Abstract] [Full Text] [PDF]

				G. Anastassiou, V. Rebmann, S. Wagner, N. Bornfeld, and H. Grosse-Wilde Expression of Classic and Nonclassic HLA Class I Antigens in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2016 - 2019. [Abstract] [Full Text] [PDF]

				H. M. H. Hurks, M. M. Valter, L. Wilson, I. Hilgert, P. J. van den Elsen, and M. J. Jager Uveal Melanoma: No Expression of HLA-G Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3081 - 3084. [Abstract] [Full Text] [PDF]

				C. Ericsson, S. Seregard, A. Bartolazzi, E. Levitskaya, S. Ferrone, R. Kiessling, and O. Larsson Association of HLA Class I and Class II Antigen Expression and Mortality in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2153 - 2156. [Abstract] [Full Text] [PDF]

				R. P. M. Sutmuller, L. R. H. M. Schurmans, L. M. van Duivenvoorde, J. A. Tine, E. I. H. van der Voort, R. E. M. Toes, C. J. M. Melief, M. J. Jager, and R. Offringa Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100 J. Immunol., December 15, 2000; 165(12): 7308 - 7315. [Abstract] [Full Text] [PDF]

				A. C. Repp, E. S. Mayhew, S. Apte, and J. Y. Niederkorn Human Uveal Melanoma Cells Produce Macrophage Migration-Inhibitory Factor to Prevent Lysis by NK Cells J. Immunol., July 15, 2000; 165(2): 710 - 715. [Abstract] [Full Text] [PDF]